Search research articles
Contact Us
Filters
Showing results (51-60 of 175) with videos related to
Page
of 18
Sort By:
Digestive Diseases and Sciences
|
April 15, 2019
Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab
Tanja Grandinetti, Luc Biedermann, Christian Bussmann, et al.
Clinical and Translational Gastroenterology
|
February 26, 2019
Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use
Thomas Greuter, Jeffrey A Alexander, Alex Straumann, et al.
The Journal of Allergy and Clinical Immunology
|
August 6, 2008
Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis
Alex Straumann, Christian Bussmann, Sébastien Conus, et al.
Digestion
|
February 1, 2013
Active eosinophilic esophagitis is associated with impaired elimination of budesonide by cytochrome P450 3A enzymes
Karin Dilger, Luis Lopez-Lazaro, Claudia Marx, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
October 5, 2020
How to approach adult patients with asymptomatic esophageal eosinophilia
Philipp Schreiner, Luc Biedermann, Thomas Greuter, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 22, 2022
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction
Fritz Ruprecht Murray, Andrea Kreienbühl, Alex Straumann, et al.
Allergy
|
February 8, 2025
A Distinct Genetic Signature Differentiates Inflamed and Noninflamed Fibrotic Tissues in Eosinophilic Esophagitis Patients
Emilie Gueguen, Yasser Morsy, Luc Biedermann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 25, 2025
Open-label, phase 2a pilot study evaluating the efficacy and tolerability of topical mesalamine treatment in adult patients with active eosinophilic esophagitis
Thomas Greuter, Alex Straumann, Andrea Kreienbühl, et al.
Therapeutic Advances in Gastroenterology
|
June 23, 2020
Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
Stephan Miehlke, Alfredo J Lucendo, Alex Straumann, et al.
Journal of Crohn'S & Colitis
|
March 9, 2012
Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers
Alain M Schoepfer, Stephan Vavricka, Nadine Zahnd-Straumann, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 175) with videos related to
Sort By:
Page
of 18
Digestive Diseases and Sciences
|
April 15, 2019
Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab
Tanja Grandinetti, Luc Biedermann, Christian Bussmann, et al.
Clinical and Translational Gastroenterology
|
February 26, 2019
Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use
Thomas Greuter, Jeffrey A Alexander, Alex Straumann, et al.
The Journal of Allergy and Clinical Immunology
|
August 6, 2008
Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis
Alex Straumann, Christian Bussmann, Sébastien Conus, et al.
Digestion
|
February 1, 2013
Active eosinophilic esophagitis is associated with impaired elimination of budesonide by cytochrome P450 3A enzymes
Karin Dilger, Luis Lopez-Lazaro, Claudia Marx, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
October 5, 2020
How to approach adult patients with asymptomatic esophageal eosinophilia
Philipp Schreiner, Luc Biedermann, Thomas Greuter, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 22, 2022
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction
Fritz Ruprecht Murray, Andrea Kreienbühl, Alex Straumann, et al.
Allergy
|
February 8, 2025
A Distinct Genetic Signature Differentiates Inflamed and Noninflamed Fibrotic Tissues in Eosinophilic Esophagitis Patients
Emilie Gueguen, Yasser Morsy, Luc Biedermann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 25, 2025
Open-label, phase 2a pilot study evaluating the efficacy and tolerability of topical mesalamine treatment in adult patients with active eosinophilic esophagitis
Thomas Greuter, Alex Straumann, Andrea Kreienbühl, et al.
Therapeutic Advances in Gastroenterology
|
June 23, 2020
Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence
Stephan Miehlke, Alfredo J Lucendo, Alex Straumann, et al.
Journal of Crohn'S & Colitis
|
March 9, 2012
Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers
Alain M Schoepfer, Stephan Vavricka, Nadine Zahnd-Straumann, et al.
Page
of 18